Drotrecogin alfa in patients with burns and soft tissue injury.
Department of Surgery, University of Michigan, Ann Arbor, Michigan, USA.
Melissa E
ME
Brunsvold
Saman
S
Arbabi
Mary
M
Dimo
Wendy
W
Wahl
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D002056:Burns / Q000150:complications*; D002648:Child; D002675:Child, Preschool; D006801:Humans; D011695:IgA Vasculitis / Q000150:complications*; D007262:Infusions, Intravenous; D015601:Injury Severity Score; D008875:Middle Aged; D053717:Pneumonia, Ventilator-Associated / Q000150:complications / Q000188:drug therapy; D011486:Protein C / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000627:therapeutic use; D012189:Retrospective Studies; D018805:Sepsis / Q000209:etiology / Q000517:prevention & control*; D013262:Stevens-Johnson Syndrome / Q000150:complications*
D000890:Anti-Infective Agents; D011486:Protein C; D011994:Recombinant Proteins; C421124:drotrecogin alfa activated